speb/financial-data huggingface dataset:
BSN.DE balance_sheet (annual, 2023-12-31) — Common Stock: 169000000.00
BSN.DE balance_sheet (annual, 2023-12-31) — Common Stock Equity: 16176000000.00
BSN.DE cash_flow (annual, 2023-12-31) — Common Stock Issuance: 69000000.00
BSN.DE cash_flow (annual, 2023-12-31) — Common Stock Payments: 0.00
BSN.DE income_statement (annual, 2023-12-31) — Cost Of Revenue: 14535000000.00
BSN.DE balance_sheet (annual, 2023-12-31) — Current Assets: 12916000000.00
BSN.DE balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 192000000.00
BSN.DE balance_sheet (annual, 2023-12-31) — Current Debt: 4962000000.00
BSN.DE balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 5154000000.00
BSN.DE balance_sheet (annual, 2023-12-31) — Current Liabilities: 13982000000.00
BSN.DE balance_sheet (annual, 2023-12-31) — Current Provisions: 155000000.00
BSN.DE cash_flow (annual, 2023-12-31) — Deferred Tax: -46000000.00
BSN.DE cash_flow (annual, 2023-12-31) — Depreciation: 1611000000.00
BSN.DE cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 1611000000.00
BSN.DE balance_sheet (annual, 2023-12-31) — Derivative Product Liabilities: 293000000.00
BSN.DE income_statement (annual, 2023-12-31) — Diluted Average Shares: 641738674.00
BSN.DE income_statement (annual, 2023-12-31) — Diluted EPS: 1.36
BSN.DE income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: 873000000.00
BSN.DE income_statement (annual, 2023-12-31) — EBIT: 2199000000.00
BSN.DE income_statement (annual, 2023-12-31) — EBITDA: 3810000000.00
BSN.DE cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: -503000000.00
BSN.DE cash_flow (annual, 2023-12-31) — End Cash Position: 1099000000.00
BSN.DE balance_sheet (annual, 2023-12-31) — Financial Assets: 34000000.00
BSN.DE cash_flow (annual, 2023-12-31) — Financing Cash Flow: -2057000000.00
BSN.DE balance_sheet (annual, 2023-12-31) — Finished Goods: 1306000000.00
BSN.DE cash_flow (annual, 2023-12-31) — Free Cash Flow: 2595000000.00
BSN.DE cash_flow (annual, 2023-12-31) — Gain Loss On Sale Of PPE: -7000000.00
BSN.DE income_statement (annual, 2023-12-31) — General And Administrative Expense: 2748000000.00
BSN.DE balance_sheet (annual, 2023-12-31) — Goodwill: 17340000000.00
BSN.DE balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 23094000000.00
BSN.DE balance_sheet (annual, 2023-12-31) — Gross Accounts Receivable: 3042000000.00
BSN.DE balance_sheet (annual, 2023-12-31) — Gross PPE: 16059000000.00
BSN.DE income_statement (annual, 2023-12-31) — Gross Profit: 13084000000.00
BSN.DE balance_sheet (annual, 2023-12-31) — Hedging Assets Current: 54000000.00
BSN.DE balance_sheet (annual, 2023-12-31) — Held To Maturity Securities: 114000000.00
BSN.DE income_statement (annual, 2023-12-31) — Impairment Of Capital Assets: 95000000.00
BSN.DE income_statement (annual, 2023-12-31) — Interest Expense: 513000000.00
BSN.DE income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 513000000.00
BSN.DE income_statement (annual, 2023-12-31) — Interest Income: 341000000.00
BSN.DE income_statement (annual, 2023-12-31) — Interest Income Non Operating: 341000000.00
BSN.DE cash_flow (annual, 2023-12-31) — Interest Paid Cff: -18000000.00
BSN.DE balance_sheet (annual, 2023-12-31) — Inventories Adjustments Allowances: -283000000.00
BSN.DE balance_sheet (annual, 2023-12-31) — Inventory: 2341000000.00
BSN.DE balance_sheet (annual, 2023-12-31) — Invested Capital: 30897000000.00
BSN.DE cash_flow (annual, 2023-12-31) — Investing Cash Flow: -834000000.00
BSN.DE balance_sheet (annual, 2023-12-31) — Investmentin Financial Assets: 506000000.00
BSN.DE balance_sheet (annual, 2023-12-31) — Investments In Other Ventures Under Equity Method: 740000000.00
BSN.DE balance_sheet (annual, 2023-12-31) — Investmentsin Associatesat Cost: 416000000.00
BSN.DE cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 69000000.00
BSN.DE cash_flow (annual, 2023-12-31) — Issuance Of Debt: 1597000000.00
BSN.DE balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 687000000.00
BSN.DE balance_sheet (annual, 2023-12-31) — Long Term Debt: 9759000000.00
BSN.DE balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 10447000000.00
BSN.DE cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 1597000000.00
BSN.DE cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -2602000000.00
BSN.DE balance_sheet (annual, 2023-12-31) — Long Term Equity Investment: 740000000.00
BSN.DE balance_sheet (annual, 2023-12-31) — Long Term Provisions: 730000000.00
BSN.DE balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 8472000000.00
BSN.DE balance_sheet (annual, 2023-12-31) — Minority Interest: 46000000.00
BSN.DE income_statement (annual, 2023-12-31) — Minority Interests: -72000000.00
BSN.DE cash_flow (annual, 2023-12-31) — Net Business Purchase And Sale: 15000000.00
BSN.DE cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: 69000000.00
BSN.DE balance_sheet (annual, 2023-12-31) — Net Debt: 12358000000.00
BSN.DE income_statement (annual, 2023-12-31) — Net Income: 881000000.00
BSN.DE income_statement (annual, 2023-12-31) — Net Income Common Stockholders: 873000000.00
BSN.DE income_statement (annual, 2023-12-31) — Net Income Continuous Operations: 954000000.00
BSN.DE income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: 881000000.00
BSN.DE income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: 881000000.00
BSN.DE cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: 953000000.00
BSN.DE income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: 953000000.00
BSN.DE income_statement (annual, 2023-12-31) — Net Interest Income: -357000000.00
BSN.DE cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: -428000000.00
BSN.DE cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: -1005000000.00
BSN.DE income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: -357000000.00
BSN.DE cash_flow (annual, 2023-12-31) — Net Other Financing Charges: -339000000.00
BSN.DE balance_sheet (annual, 2023-12-31) — Net PPE: 6441000000.00
BSN.DE cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: 15000000.00
BSN.DE cash_flow (annual, 2023-12-31) — Net Short Term Debt Issuance: 577000000.00
BSN.DE balance_sheet (annual, 2023-12-31) — Net Tangible Assets: -6918000000.00
BSN.DE balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Assets: 746000000.00
BSN.DE balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Liabilities: 1489000000.00
BSN.DE balance_sheet (annual, 2023-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 904000000.00
BSN.DE income_statement (annual, 2023-12-31) — Normalized EBITDA: 5136000000.00
BSN.DE income_statement (annual, 2023-12-31) — Normalized Income: 1875500000.00
BSN.DE cash_flow (annual, 2023-12-31) — Operating Cash Flow: 3442000000.00
BSN.DE income_statement (annual, 2023-12-31) — Operating Income: 3489000000.00
BSN.DE income_statement (annual, 2023-12-31) — Operating Revenue: 27619000000.00
BSN.DE balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 641871882.00
BSN.DE cash_flow (annual, 2023-12-31) — Other Cash Adjustment Outside Changein Cash: 1264000000.00
BSN.DE balance_sheet (annual, 2023-12-31) — Other Current Assets: 1222000000.00
BSN.DE balance_sheet (annual, 2023-12-31) — Other Current Liabilities: 401000000.00
BSN.DE balance_sheet (annual, 2023-12-31) — Other Equity Interest: 1000000.00
BSN.DE balance_sheet (annual, 2023-12-31) — Other Intangible Assets: 5754000000.00
BSN.DE balance_sheet (annual, 2023-12-31) — Other Inventories: 181000000.00
BSN.DE cash_flow (annual, 2023-12-31) — Other Non Cash Items: 658000000.00
BSN.DE balance_sheet (annual, 2023-12-31) — Other Non Current Assets: -1000000.00
BSN.DE balance_sheet (annual, 2023-12-31) — Other Non Current Liabilities: 1000000.00
BSN.DE income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: -120000000.00
BSN.DE income_statement (annual, 2023-12-31) — Other Operating Expenses: 161000000.00
BSN.DE balance_sheet (annual, 2023-12-31) — Other Payable: 1812000000.00
BSN.DE balance_sheet (annual, 2023-12-31) — Other Properties: 2422000000.00
BSN.DE balance_sheet (annual, 2023-12-31) — Other Receivables: 3000000.00
BSN.DE balance_sheet (annual, 2023-12-31) — Other Short Term Investments: 3638000000.00
BSN.DE income_statement (annual, 2023-12-31) — Other Special Charges: 1128000000.00
BSN.DE income_statement (annual, 2023-12-31) — Otherunder Preferred Stock Dividend: 8000000.00
BSN.DE balance_sheet (annual, 2023-12-31) — Payables: 6591000000.00
BSN.DE balance_sheet (annual, 2023-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 1143000000.00
BSN.DE income_statement (annual, 2023-12-31) — Preferred Stock Dividends: 0.00
BSN.DE income_statement (annual, 2023-12-31) — Pretax Income: 1686000000.00
BSN.DE balance_sheet (annual, 2023-12-31) — Properties: 5165000000.00
BSN.DE cash_flow (annual, 2023-12-31) — Provisionand Write Offof Assets: -52000000.00
BSN.DE cash_flow (annual, 2023-12-31) — Purchase Of Business: -162000000.00
BSN.DE balance_sheet (annual, 2023-12-31) — Raw Materials: 1318000000.00
BSN.DE income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 14535000000.00
BSN.DE income_statement (annual, 2023-12-31) — Reconciled Depreciation: 1611000000.00
BSN.DE cash_flow (annual, 2023-12-31) — Repayment Of Debt: -2602000000.00
BSN.DE cash_flow (annual, 2023-12-31) — Repurchase Of Capital Stock: 0.00
BSN.DE income_statement (annual, 2023-12-31) — Research And Development: 398000000.00
BSN.DE income_statement (annual, 2023-12-31) — Restructuring And Mergern Acquisition: 103000000.00
BSN.DE balance_sheet (annual, 2023-12-31) — Retained Earnings: 16845000000.00
BSN.DE cash_flow (annual, 2023-12-31) — Sale Of Business: 177000000.00
BSN.DE cash_flow (annual, 2023-12-31) — Sale Of PPE: 15000000.00
BSN.DE income_statement (annual, 2023-12-31) — Selling And Marketing Expense: 6288000000.00
BSN.DE income_statement (annual, 2023-12-31) — Selling General And Administration: 9036000000.00
BSN.DE balance_sheet (annual, 2023-12-31) — Share Issued: 677773128.00
BSN.DE income_statement (annual, 2023-12-31) — Special Income Charges: -1326000000.00
BSN.DE cash_flow (annual, 2023-12-31) — Stock Based Compensation: 61000000.00
BSN.DE balance_sheet (annual, 2023-12-31) — Stockholders Equity: 16176000000.00
BSN.DE balance_sheet (annual, 2023-12-31) — Tangible Book Value: -6918000000.00
BSN.DE income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: -331500000.00
BSN.DE income_statement (annual, 2023-12-31) — Tax Provision: 768000000.00
BSN.DE income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.25
BSN.DE balance_sheet (annual, 2023-12-31) — Total Assets: 44486000000.00
BSN.DE balance_sheet (annual, 2023-12-31) — Total Capitalization: 25935000000.00
BSN.DE balance_sheet (annual, 2023-12-31) — Total Debt: 15601000000.00
BSN.DE balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 16222000000.00
BSN.DE income_statement (annual, 2023-12-31) — Total Expenses: 24130000000.00
BSN.DE balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 28264000000.00
BSN.DE balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 31570000000.00
BSN.DE balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 14282000000.00
BSN.DE income_statement (annual, 2023-12-31) — Total Operating Income As Reported: 2042000000.00
BSN.DE income_statement (annual, 2023-12-31) — Total Other Finance Cost: 185000000.00
BSN.DE income_statement (annual, 2023-12-31) — Total Unusual Items: -1326000000.00
BSN.DE income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: -1326000000.00
BSN.DE balance_sheet (annual, 2023-12-31) — Tradeand Other Payables Non Current: 418000000.00
BSN.DE balance_sheet (annual, 2023-12-31) — Treasury Shares Number: 35901246.00
BSN.DE balance_sheet (annual, 2023-12-31) — Treasury Stock: 1552000000.00
BSN.DE balance_sheet (annual, 2023-12-31) — Work In Process: 287000000.00
BSN.DE balance_sheet (annual, 2023-12-31) — Working Capital: -1066000000.00
BSN.DE income_statement (annual, 2024-12-31) — +Operating Expense: 10141000000.00
BSN.DE income_statement (annual, 2024-12-31) — +Total Revenue: 27376000000.00
BSN.DE balance_sheet (annual, 2024-12-31) — Accounts Payable: 5147000000.00
BSN.DE balance_sheet (quarterly, 2024-12-31) — Accounts Payable: 5147000000.00
BSN.DE balance_sheet (annual, 2024-12-31) — Accounts Receivable: 2922000000.00
BSN.DE balance_sheet (quarterly, 2024-12-31) — Accounts Receivable: 2922000000.00
BSN.DE balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -10420000000.00
BSN.DE balance_sheet (quarterly, 2024-12-31) — Accumulated Depreciation: -10420000000.00
BSN.DE balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 5331000000.00
BSN.DE balance_sheet (quarterly, 2024-12-31) — Additional Paid In Capital: 5331000000.00
BSN.DE balance_sheet (annual, 2024-12-31) — Allowance For Doubtful Accounts Receivable: -113000000.00
BSN.DE balance_sheet (quarterly, 2024-12-31) — Allowance For Doubtful Accounts Receivable: -113000000.00
BSN.DE balance_sheet (annual, 2024-12-31) — Assets Held For Sale Current: 0.00
BSN.DE balance_sheet (quarterly, 2024-12-31) — Assets Held For Sale Current: 0.00
BSN.DE balance_sheet (annual, 2024-12-31) — Available For Sale Securities: 415000000.00
BSN.DE balance_sheet (quarterly, 2024-12-31) — Available For Sale Securities: 415000000.00
BSN.DE income_statement (annual, 2024-12-31) — Basic Average Shares: 643283916.00
BSN.DE income_statement (annual, 2024-12-31) — Basic EPS: 3.14
BSN.DE cash_flow (annual, 2024-12-31) — Beginning Cash Position: 1099000000.00
BSN.DE cash_flow (annual, 2024-12-31) — Capital Expenditure: -923000000.00
BSN.DE cash_flow (annual, 2024-12-31) — Capital Expenditure Reported: -923000000.00
BSN.DE balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 868000000.00
BSN.DE balance_sheet (quarterly, 2024-12-31) — Capital Lease Obligations: 868000000.00
BSN.DE balance_sheet (annual, 2024-12-31) — Capital Stock: 170000000.00
BSN.DE balance_sheet (quarterly, 2024-12-31) — Capital Stock: 170000000.00
BSN.DE balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 1475000000.00
BSN.DE balance_sheet (quarterly, 2024-12-31) — Cash And Cash Equivalents: 1475000000.00
BSN.DE balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 6160000000.00
BSN.DE balance_sheet (quarterly, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 6160000000.00
BSN.DE cash_flow (annual, 2024-12-31) — Cash Dividends Paid: -1348000000.00
BSN.DE balance_sheet (annual, 2024-12-31) — Cash Financial: 1475000000.00
BSN.DE balance_sheet (quarterly, 2024-12-31) — Cash Financial: 1475000000.00
BSN.DE cash_flow (annual, 2024-12-31) — Change In Inventory: 50000000.00
BSN.DE cash_flow (annual, 2024-12-31) — Change In Other Current Assets: 137000000.00
BSN.DE cash_flow (annual, 2024-12-31) — Change In Payable: 353000000.00
BSN.DE cash_flow (annual, 2024-12-31) — Change In Receivables: -7000000.00
BSN.DE cash_flow (annual, 2024-12-31) — Change In Working Capital: 533000000.00
BSN.DE cash_flow (annual, 2024-12-31) — Changes In Cash: -449000000.00
BSN.DE balance_sheet (annual, 2024-12-31) — Common Stock: 170000000.00
BSN.DE balance_sheet (quarterly, 2024-12-31) — Common Stock: 170000000.00
BSN.DE balance_sheet (annual, 2024-12-31) — Common Stock Equity: 17795000000.00
BSN.DE balance_sheet (quarterly, 2024-12-31) — Common Stock Equity: 17795000000.00
BSN.DE cash_flow (annual, 2024-12-31) — Common Stock Issuance: 76000000.00
BSN.DE cash_flow (annual, 2024-12-31) — Common Stock Payments: 0.00
BSN.DE income_statement (annual, 2024-12-31) — Cost Of Revenue: 13769000000.00
BSN.DE balance_sheet (annual, 2024-12-31) — Current Assets: 12786000000.00
BSN.DE balance_sheet (quarterly, 2024-12-31) — Current Assets: 12786000000.00
BSN.DE balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 213000000.00
BSN.DE balance_sheet (quarterly, 2024-12-31) — Current Capital Lease Obligation: 213000000.00
BSN.DE balance_sheet (annual, 2024-12-31) — Current Debt: 4049000000.00
BSN.DE balance_sheet (quarterly, 2024-12-31) — Current Debt: 4049000000.00
BSN.DE balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 4262000000.00
BSN.DE balance_sheet (quarterly, 2024-12-31) — Current Debt And Capital Lease Obligation: 4262000000.00
BSN.DE balance_sheet (annual, 2024-12-31) — Current Liabilities: 13732000000.00
BSN.DE balance_sheet (quarterly, 2024-12-31) — Current Liabilities: 13732000000.00
BSN.DE balance_sheet (annual, 2024-12-31) — Current Provisions: 186000000.00
BSN.DE balance_sheet (quarterly, 2024-12-31) — Current Provisions: 186000000.00
BSN.DE cash_flow (annual, 2024-12-31) — Deferred Tax: 61000000.00
BSN.DE cash_flow (annual, 2024-12-31) — Depreciation: 1168000000.00
BSN.DE cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 1168000000.00
BSN.DE balance_sheet (annual, 2024-12-31) — Derivative Product Liabilities: 246000000.00
BSN.DE balance_sheet (quarterly, 2024-12-31) — Derivative Product Liabilities: 246000000.00
BSN.DE income_statement (annual, 2024-12-31) — Diluted Average Shares: 644436743.00
BSN.DE income_statement (annual, 2024-12-31) — Diluted EPS: 3.13
BSN.DE income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: 2018000000.00
BSN.DE income_statement (annual, 2024-12-31) — EBIT: 3599000000.00
BSN.DE income_statement (annual, 2024-12-31) — EBITDA: 4767000000.00
BSN.DE cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: -2000000.00
BSN.DE cash_flow (annual, 2024-12-31) — End Cash Position: 647000000.00
BSN.DE balance_sheet (annual, 2024-12-31) — Financial Assets: 3000000.00
BSN.DE balance_sheet (quarterly, 2024-12-31) — Financial Assets: 3000000.00
BSN.DE cash_flow (annual, 2024-12-31) — Financing Cash Flow: -3817000000.00
BSN.DE balance_sheet (annual, 2024-12-31) — Finished Goods: 1215000000.00
BSN.DE balance_sheet (quarterly, 2024-12-31) — Finished Goods: 1215000000.00
BSN.DE cash_flow (annual, 2024-12-31) — Free Cash Flow: 2908000000.00
BSN.DE cash_flow (annual, 2024-12-31) — Gain Loss On Sale Of PPE: -225000000.00
BSN.DE income_statement (annual, 2024-12-31) — General And Administrative Expense: 2928000000.00
BSN.DE balance_sheet (annual, 2024-12-31) — Goodwill: 18062000000.00
BSN.DE balance_sheet (quarterly, 2024-12-31) — Goodwill: 18062000000.00
BSN.DE balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 24008000000.00
BSN.DE balance_sheet (quarterly, 2024-12-31) — Goodwill And Other Intangible Assets: 24008000000.00
BSN.DE balance_sheet (annual, 2024-12-31) — Gross Accounts Receivable: 3035000000.00
BSN.DE balance_sheet (quarterly, 2024-12-31) — Gross Accounts Receivable: 3035000000.00
BSN.DE balance_sheet (annual, 2024-12-31) — Gross PPE: 16939000000.00
BSN.DE balance_sheet (quarterly, 2024-12-31) — Gross PPE: 16939000000.00
BSN.DE income_statement (annual, 2024-12-31) — Gross Profit: 13607000000.00
BSN.DE balance_sheet (annual, 2024-12-31) — Hedging Assets Current: 97000000.00
BSN.DE balance_sheet (quarterly, 2024-12-31) — Hedging Assets Current: 97000000.00
BSN.DE balance_sheet (annual, 2024-12-31) — Held To Maturity Securities: 118000000.00
BSN.DE balance_sheet (quarterly, 2024-12-31) — Held To Maturity Securities: 118000000.00
BSN.DE income_statement (annual, 2024-12-31) — Impairment Of Capital Assets: 51000000.00
BSN.DE income_statement (annual, 2024-12-31) — Interest Expense: 600000000.00
BSN.DE income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 600000000.00
BSN.DE income_statement (annual, 2024-12-31) — Interest Income: 403000000.00
BSN.DE income_statement (annual, 2024-12-31) — Interest Income Non Operating: 403000000.00
BSN.DE cash_flow (annual, 2024-12-31) — Interest Paid Cff: -5000000.00
BSN.DE balance_sheet (annual, 2024-12-31) — Inventories Adjustments Allowances: -229000000.00
BSN.DE balance_sheet (quarterly, 2024-12-31) — Inventories Adjustments Allowances: -229000000.00
BSN.DE balance_sheet (annual, 2024-12-31) — Inventory: 2277000000.00
BSN.DE balance_sheet (quarterly, 2024-12-31) — Inventory: 2277000000.00
BSN.DE balance_sheet (annual, 2024-12-31) — Invested Capital: 31118000000.00
BSN.DE balance_sheet (quarterly, 2024-12-31) — Invested Capital: 31118000000.00
BSN.DE cash_flow (annual, 2024-12-31) — Investing Cash Flow: -463000000.00
BSN.DE balance_sheet (annual, 2024-12-31) — Investmentin Financial Assets: 533000000.00
BSN.DE balance_sheet (quarterly, 2024-12-31) — Investmentin Financial Assets: 533000000.00
BSN.DE balance_sheet (annual, 2024-12-31) — Investments In Other Ventures Under Equity Method: 908000000.00
BSN.DE balance_sheet (quarterly, 2024-12-31) — Investments In Other Ventures Under Equity Method: 908000000.00
BSN.DE balance_sheet (annual, 2024-12-31) — Investmentsin Associatesat Cost: 583000000.00
BSN.DE balance_sheet (quarterly, 2024-12-31) — Investmentsin Associatesat Cost: 583000000.00
BSN.DE cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 76000000.00
BSN.DE cash_flow (annual, 2024-12-31) — Issuance Of Debt: 1397000000.00
BSN.DE balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 655000000.00
BSN.DE balance_sheet (quarterly, 2024-12-31) — Long Term Capital Lease Obligation: 655000000.00
BSN.DE balance_sheet (annual, 2024-12-31) — Long Term Debt: 9274000000.00
BSN.DE balance_sheet (quarterly, 2024-12-31) — Long Term Debt: 9274000000.00
BSN.DE balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 9929000000.00
BSN.DE balance_sheet (quarterly, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 9929000000.00
BSN.DE cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 1397000000.00
BSN.DE cash_flow (annual, 2024-12-31) — Long Term Debt Payments: -2006000000.00
BSN.DE balance_sheet (annual, 2024-12-31) — Long Term Equity Investment: 908000000.00
BSN.DE balance_sheet (quarterly, 2024-12-31) — Long Term Equity Investment: 908000000.00
BSN.DE balance_sheet (annual, 2024-12-31) — Long Term Provisions: 710000000.00
BSN.DE balance_sheet (quarterly, 2024-12-31) — Long Term Provisions: 710000000.00
BSN.DE balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 9257000000.00
BSN.DE balance_sheet (quarterly, 2024-12-31) — Machinery Furniture Equipment: 9257000000.00
BSN.DE balance_sheet (annual, 2024-12-31) — Minority Interest: 59000000.00
BSN.DE balance_sheet (quarterly, 2024-12-31) — Minority Interest: 59000000.00
BSN.DE income_statement (annual, 2024-12-31) — Minority Interests: -79000000.00
BSN.DE cash_flow (annual, 2024-12-31) — Net Business Purchase And Sale: 354000000.00
BSN.DE cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 76000000.00
BSN.DE balance_sheet (annual, 2024-12-31) — Net Debt: 11848000000.00
BSN.DE balance_sheet (quarterly, 2024-12-31) — Net Debt: 11848000000.00
BSN.DE income_statement (annual, 2024-12-31) — Net Income: 2021000000.00
BSN.DE income_statement (annual, 2024-12-31) — Net Income Common Stockholders: 2018000000.00
BSN.DE income_statement (annual, 2024-12-31) — Net Income Continuous Operations: 2100000000.00
BSN.DE income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 2021000000.00
BSN.DE income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 2021000000.00
BSN.DE cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: 2100000000.00
BSN.DE income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: 2100000000.00
BSN.DE income_statement (annual, 2024-12-31) — Net Interest Income: -380000000.00
BSN.DE cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: -1417000000.00
BSN.DE cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: -609000000.00
BSN.DE income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: -380000000.00
BSN.DE cash_flow (annual, 2024-12-31) — Net Other Financing Charges: -1015000000.00
BSN.DE cash_flow (annual, 2024-12-31) — Net Other Investing Changes: 1000000.00
BSN.DE balance_sheet (annual, 2024-12-31) — Net PPE: 6519000000.00
BSN.DE balance_sheet (quarterly, 2024-12-31) — Net PPE: 6519000000.00
BSN.DE cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: 18000000.00
BSN.DE cash_flow (annual, 2024-12-31) — Net Short Term Debt Issuance: -808000000.00
BSN.DE balance_sheet (annual, 2024-12-31) — Net Tangible Assets: -6213000000.00
BSN.DE balance_sheet (quarterly, 2024-12-31) — Net Tangible Assets: -6213000000.00
BSN.DE balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Assets: 528000000.00
BSN.DE balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Taxes Assets: 528000000.00
BSN.DE balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Liabilities: 1480000000.00
BSN.DE balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Taxes Liabilities: 1480000000.00
BSN.DE balance_sheet (annual, 2024-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 900000000.00
BSN.DE balance_sheet (quarterly, 2024-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 900000000.00
BSN.DE income_statement (annual, 2024-12-31) — Normalized EBITDA: 4830000000.00
BSN.DE income_statement (annual, 2024-12-31) — Normalized Income: 2064470000.00
BSN.DE cash_flow (annual, 2024-12-31) — Operating Cash Flow: 3831000000.00
BSN.DE income_statement (annual, 2024-12-31) — Operating Income: 3466000000.00
BSN.DE income_statement (annual, 2024-12-31) — Operating Revenue: 27376000000.00
BSN.DE balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 644157323.00
BSN.DE balance_sheet (quarterly, 2024-12-31) — Ordinary Shares Number: 644157323.00
BSN.DE cash_flow (annual, 2024-12-31) — Other Cash Adjustment Outside Changein Cash: -1000000.00
BSN.DE balance_sheet (annual, 2024-12-31) — Other Current Assets: 1328000000.00
BSN.DE balance_sheet (quarterly, 2024-12-31) — Other Current Assets: 1328000000.00
BSN.DE balance_sheet (annual, 2024-12-31) — Other Current Liabilities: 519000000.00
BSN.DE balance_sheet (quarterly, 2024-12-31) — Other Current Liabilities: 519000000.00
BSN.DE balance_sheet (annual, 2024-12-31) — Other Equity Interest: 1000000.00
BSN.DE balance_sheet (quarterly, 2024-12-31) — Other Equity Interest: 1000000.00
BSN.DE balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 5946000000.00
BSN.DE balance_sheet (quarterly, 2024-12-31) — Other Intangible Assets: 5946000000.00
BSN.DE cash_flow (annual, 2024-12-31) — Other Non Cash Items: 151000000.00
BSN.DE balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 1000000.00
BSN.DE balance_sheet (quarterly, 2024-12-31) — Other Non Current Assets: 1000000.00
BSN.DE balance_sheet (annual, 2024-12-31) — Other Non Current Liabilities: -1000000.00
BSN.DE balance_sheet (quarterly, 2024-12-31) — Other Non Current Liabilities: -1000000.00
BSN.DE income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: -25000000.00
BSN.DE income_statement (annual, 2024-12-31) — Other Operating Expenses: 194000000.00
BSN.DE balance_sheet (quarterly, 2024-12-31) — Other Payable: 1920000000.00
BSN.DE balance_sheet (annual, 2024-12-31) — Other Properties: 2448000000.00
BSN.DE balance_sheet (quarterly, 2024-12-31) — Other Properties: 2448000000.00
BSN.DE balance_sheet (annual, 2024-12-31) — Other Receivables: 2000000.00
BSN.DE balance_sheet (quarterly, 2024-12-31) — Other Receivables: 2000000.00
BSN.DE balance_sheet (annual, 2024-12-31) — Other Short Term Investments: 4685000000.00
BSN.DE balance_sheet (quarterly, 2024-12-31) — Other Short Term Investments: 4685000000.00
BSN.DE income_statement (annual, 2024-12-31) — Other Special Charges: -310000000.00
BSN.DE income_statement (annual, 2024-12-31) — Otherunder Preferred Stock Dividend: 3000000.00
BSN.DE balance_sheet (annual, 2024-12-31) — Payables: 7067000000.00
BSN.DE balance_sheet (quarterly, 2024-12-31) — Payables: 7067000000.00
BSN.DE balance_sheet (annual, 2024-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 1283000000.00
BSN.DE balance_sheet (quarterly, 2024-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 1283000000.00
BSN.DE income_statement (annual, 2024-12-31) — Preferred Stock Dividends: 0.00
BSN.DE income_statement (annual, 2024-12-31) — Pretax Income: 2999000000.00
BSN.DE balance_sheet (annual, 2024-12-31) — Properties: 5234000000.00
BSN.DE balance_sheet (quarterly, 2024-12-31) — Properties: 5234000000.00
BSN.DE cash_flow (annual, 2024-12-31) — Provisionand Write Offof Assets: -21000000.00
BSN.DE cash_flow (annual, 2024-12-31) — Purchase Of Business: -153000000.00
BSN.DE balance_sheet (annual, 2024-12-31) — Raw Materials: 1291000000.00
BSN.DE balance_sheet (quarterly, 2024-12-31) — Raw Materials: 1291000000.00
BSN.DE income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 13769000000.00
BSN.DE income_statement (annual, 2024-12-31) — Reconciled Depreciation: 1168000000.00
BSN.DE cash_flow (annual, 2024-12-31) — Repayment Of Debt: -2006000000.00
BSN.DE cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: 0.00
BSN.DE income_statement (annual, 2024-12-31) — Research And Development: 447000000.00
BSN.DE income_statement (annual, 2024-12-31) — Restructuring And Mergern Acquisition: 322000000.00
BSN.DE balance_sheet (annual, 2024-12-31) — Retained Earnings: 17546000000.00
BSN.DE balance_sheet (quarterly, 2024-12-31) — Retained Earnings: 17546000000.00
BSN.DE cash_flow (annual, 2024-12-31) — Sale Of Business: 507000000.00
BSN.DE cash_flow (annual, 2024-12-31) — Sale Of PPE: 18000000.00
BSN.DE income_statement (annual, 2024-12-31) — Selling And Marketing Expense: 6572000000.00
BSN.DE income_statement (annual, 2024-12-31) — Selling General And Administration: 9500000000.00
BSN.DE balance_sheet (annual, 2024-12-31) — Share Issued: 679553991.00
BSN.DE balance_sheet (quarterly, 2024-12-31) — Share Issued: 679553991.00
BSN.DE income_statement (annual, 2024-12-31) — Special Income Charges: -63000000.00
BSN.DE cash_flow (annual, 2024-12-31) — Stock Based Compensation: 71000000.00
BSN.DE balance_sheet (annual, 2024-12-31) — Stockholders Equity: 17795000000.00
BSN.DE balance_sheet (quarterly, 2024-12-31) — Stockholders Equity: 17795000000.00
BSN.DE balance_sheet (annual, 2024-12-31) — Tangible Book Value: -6213000000.00
BSN.DE balance_sheet (quarterly, 2024-12-31) — Tangible Book Value: -6213000000.00
BSN.DE income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: -19530000.00
BSN.DE income_statement (annual, 2024-12-31) — Tax Provision: 929000000.00
BSN.DE income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.31
BSN.DE balance_sheet (annual, 2024-12-31) — Total Assets: 45292000000.00
BSN.DE balance_sheet (quarterly, 2024-12-31) — Total Assets: 45292000000.00
BSN.DE balance_sheet (annual, 2024-12-31) — Total Capitalization: 27069000000.00
BSN.DE balance_sheet (quarterly, 2024-12-31) — Total Capitalization: 27069000000.00
BSN.DE balance_sheet (annual, 2024-12-31) — Total Debt: 14191000000.00
BSN.DE balance_sheet (quarterly, 2024-12-31) — Total Debt: 14191000000.00
BSN.DE balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 17854000000.00
BSN.DE balance_sheet (quarterly, 2024-12-31) — Total Equity Gross Minority Interest: 17854000000.00
BSN.DE income_statement (annual, 2024-12-31) — Total Expenses: 23910000000.00
BSN.DE balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 27438000000.00
BSN.DE balance_sheet (quarterly, 2024-12-31) — Total Liabilities Net Minority Interest: 27438000000.00
BSN.DE balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 32505000000.00
BSN.DE balance_sheet (quarterly, 2024-12-31) — Total Non Current Assets: 32505000000.00
BSN.DE balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 13706000000.00
BSN.DE balance_sheet (quarterly, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 13706000000.00
BSN.DE income_statement (annual, 2024-12-31) — Total Operating Income As Reported: 3379000000.00
BSN.DE income_statement (annual, 2024-12-31) — Total Other Finance Cost: 183000000.00
BSN.DE income_statement (annual, 2024-12-31) — Total Unusual Items: -63000000.00
BSN.DE income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: -63000000.00
BSN.DE balance_sheet (annual, 2024-12-31) — Tradeand Other Payables Non Current: 442000000.00
BSN.DE balance_sheet (quarterly, 2024-12-31) — Tradeand Other Payables Non Current: 442000000.00
BSN.DE balance_sheet (annual, 2024-12-31) — Treasury Shares Number: 35396668.00
BSN.DE balance_sheet (quarterly, 2024-12-31) — Treasury Shares Number: 35396668.00
BSN.DE balance_sheet (annual, 2024-12-31) — Treasury Stock: 1527000000.00
BSN.DE balance_sheet (quarterly, 2024-12-31) — Treasury Stock: 1527000000.00
BSN.DE balance_sheet (annual, 2024-12-31) — Working Capital: -946000000.00
BSN.DE balance_sheet (quarterly, 2024-12-31) — Working Capital: -946000000.00
BSN.DE balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 5384000000.00
BSN.DE balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 3220000000.00
BSN.DE balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 5420000000.00
BSN.DE balance_sheet (quarterly, 2025-06-30) — Allowance For Doubtful Accounts Receivable: -113000000.00
BSN.DE balance_sheet (quarterly, 2025-06-30) — Available For Sale Securities: 596000000.00
BSN.DE balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 886000000.00
BSN.DE balance_sheet (quarterly, 2025-06-30) — Capital Stock: 170000000.00
BSN.DE balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 1619000000.00
BSN.DE balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 6015000000.00
BSN.DE balance_sheet (quarterly, 2025-06-30) — Cash Financial: 1619000000.00
BSN.DE balance_sheet (quarterly, 2025-06-30) — Common Stock: 170000000.00
BSN.DE balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 15862000000.00
BSN.DE balance_sheet (quarterly, 2025-06-30) — Current Assets: 12897000000.00
BSN.DE balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 186000000.00
BSN.DE balance_sheet (quarterly, 2025-06-30) — Current Debt: 3777000000.00
BSN.DE balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 3963000000.00
BSN.DE balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 13616000000.00
BSN.DE balance_sheet (quarterly, 2025-06-30) — Derivative Product Liabilities: 218000000.00
BSN.DE balance_sheet (quarterly, 2025-06-30) — Financial Assets: 95000000.00
BSN.DE balance_sheet (quarterly, 2025-06-30) — Goodwill: 16765000000.00
BSN.DE balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 22335000000.00
BSN.DE balance_sheet (quarterly, 2025-06-30) — Gross Accounts Receivable: 3332000000.00
BSN.DE balance_sheet (quarterly, 2025-06-30) — Hedging Assets Current: 18000000.00
BSN.DE balance_sheet (quarterly, 2025-06-30) — Inventory: 2278000000.00
BSN.DE balance_sheet (quarterly, 2025-06-30) — Invested Capital: 29514000000.00
BSN.DE balance_sheet (quarterly, 2025-06-30) — Investmentin Financial Assets: 596000000.00
BSN.DE balance_sheet (quarterly, 2025-06-30) — Investments In Other Ventures Under Equity Method: 1009000000.00
BSN.DE balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 700000000.00
BSN.DE balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 9875000000.00
BSN.DE balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 10575000000.00
BSN.DE balance_sheet (quarterly, 2025-06-30) — Long Term Equity Investment: 1009000000.00
BSN.DE balance_sheet (quarterly, 2025-06-30) — Long Term Provisions: 693000000.00
BSN.DE balance_sheet (quarterly, 2025-06-30) — Minority Interest: 58000000.00
BSN.DE balance_sheet (quarterly, 2025-06-30) — Net Debt: 12033000000.00
BSN.DE balance_sheet (quarterly, 2025-06-30) — Net PPE: 6277000000.00
BSN.DE balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: -6473000000.00
BSN.DE balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Assets: 548000000.00
BSN.DE balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Liabilities: 1489000000.00
BSN.DE balance_sheet (quarterly, 2025-06-30) — Non Current Pension And Other Postretirement Benefit Plans: 836000000.00
BSN.DE balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 643297815.00
BSN.DE balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 1364000000.00
BSN.DE balance_sheet (quarterly, 2025-06-30) — Other Current Liabilities: 3821000000.00
BSN.DE balance_sheet (quarterly, 2025-06-30) — Other Equity Interest: -1000000.00
BSN.DE balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 5570000000.00
BSN.DE balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: -1000000.00
BSN.DE balance_sheet (quarterly, 2025-06-30) — Other Receivables: 2000000.00
BSN.DE balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 4396000000.00
BSN.DE balance_sheet (quarterly, 2025-06-30) — Payables: 5384000000.00
BSN.DE balance_sheet (quarterly, 2025-06-30) — Retained Earnings: 17229000000.00
BSN.DE balance_sheet (quarterly, 2025-06-30) — Share Issued: 681394483.00
BSN.DE balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 15862000000.00
BSN.DE balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: -6473000000.00
BSN.DE balance_sheet (quarterly, 2025-06-30) — Total Assets: 43756000000.00
BSN.DE balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 25737000000.00
BSN.DE balance_sheet (quarterly, 2025-06-30) — Total Debt: 14538000000.00
BSN.DE balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 15920000000.00
BSN.DE balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 27836000000.00
BSN.DE balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 30860000000.00
BSN.DE balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 14220000000.00
BSN.DE balance_sheet (quarterly, 2025-06-30) — Tradeand Other Payables Non Current: 410000000.00
BSN.DE balance_sheet (quarterly, 2025-06-30) — Treasury Shares Number: 38096668.00
BSN.DE balance_sheet (quarterly, 2025-06-30) — Treasury Stock: 1719000000.00
BSN.DE balance_sheet (quarterly, 2025-06-30) — Working Capital: -719000000.00
BSN.DE income_statement (annual, 2025-12-31) — +Operating Expense: 10093000000.00
BSN.DE income_statement (annual, 2025-12-31) — +Total Revenue: 27283000000.00
BSN.DE balance_sheet (annual, 2025-12-31) — Accounts Payable: 5421000000.00
BSN.DE balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 5421000000.00
BSN.DE balance_sheet (annual, 2025-12-31) — Accounts Receivable: 3042000000.00
BSN.DE balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 3042000000.00
BSN.DE balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -10344000000.00
BSN.DE balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -10344000000.00
BSN.DE balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 5420000000.00
BSN.DE balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 5420000000.00
BSN.DE balance_sheet (annual, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -109000000.00
BSN.DE balance_sheet (quarterly, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -109000000.00
BSN.DE balance_sheet (annual, 2025-12-31) — Assets Held For Sale Current: 56000000.00
BSN.DE balance_sheet (quarterly, 2025-12-31) — Assets Held For Sale Current: 56000000.00
BSN.DE balance_sheet (annual, 2025-12-31) — Available For Sale Securities: 505000000.00
BSN.DE balance_sheet (quarterly, 2025-12-31) — Available For Sale Securities: 505000000.00
BSN.DE income_statement (annual, 2025-12-31) — Basic Average Shares: 643127462.00
BSN.DE income_statement (annual, 2025-12-31) — Basic EPS: 2.82
BSN.DE cash_flow (annual, 2025-12-31) — Beginning Cash Position: 647000000.00
BSN.DE cash_flow (annual, 2025-12-31) — Capital Expenditure: -1055000000.00
BSN.DE cash_flow (annual, 2025-12-31) — Capital Expenditure Reported: -1055000000.00
BSN.DE balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 937000000.00
BSN.DE balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 937000000.00
BSN.DE balance_sheet (annual, 2025-12-31) — Capital Stock: 170000000.00
BSN.DE balance_sheet (quarterly, 2025-12-31) — Capital Stock: 170000000.00
BSN.DE balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 1983000000.00
BSN.DE balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 1983000000.00
BSN.DE balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 6571000000.00
BSN.DE balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 6571000000.00
BSN.DE cash_flow (annual, 2025-12-31) — Cash Dividends Paid: -1379000000.00
BSN.DE balance_sheet (annual, 2025-12-31) — Cash Financial: 1983000000.00
BSN.DE balance_sheet (quarterly, 2025-12-31) — Cash Financial: 1983000000.00
BSN.DE cash_flow (annual, 2025-12-31) — Change In Inventory: -192000000.00
BSN.DE cash_flow (annual, 2025-12-31) — Change In Other Current Assets: 268000000.00
BSN.DE cash_flow (annual, 2025-12-31) — Change In Payable: 527000000.00
BSN.DE cash_flow (annual, 2025-12-31) — Change In Receivables: -328000000.00
BSN.DE cash_flow (annual, 2025-12-31) — Change In Working Capital: 275000000.00
BSN.DE cash_flow (annual, 2025-12-31) — Changes In Cash: 396000000.00
BSN.DE balance_sheet (annual, 2025-12-31) — Common Stock: 170000000.00
BSN.DE balance_sheet (quarterly, 2025-12-31) — Common Stock: 170000000.00
BSN.DE balance_sheet (annual, 2025-12-31) — Common Stock Equity: 16917000000.00
BSN.DE balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 16917000000.00
BSN.DE cash_flow (annual, 2025-12-31) — Common Stock Issuance: 89000000.00
BSN.DE cash_flow (annual, 2025-12-31) — Common Stock Payments: -486000000.00
BSN.DE income_statement (annual, 2025-12-31) — Cost Of Revenue: 13473000000.00
BSN.DE balance_sheet (annual, 2025-12-31) — Current Assets: 13230000000.00
BSN.DE balance_sheet (quarterly, 2025-12-31) — Current Assets: 13230000000.00
BSN.DE balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 207000000.00
BSN.DE balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 207000000.00
BSN.DE balance_sheet (annual, 2025-12-31) — Current Debt: 4450000000.00
BSN.DE balance_sheet (quarterly, 2025-12-31) — Current Debt: 4450000000.00
BSN.DE balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 4657000000.00
BSN.DE balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 4657000000.00
BSN.DE balance_sheet (annual, 2025-12-31) — Current Liabilities: 14625000000.00
BSN.DE balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 14625000000.00
BSN.DE balance_sheet (annual, 2025-12-31) — Current Provisions: 215000000.00
BSN.DE balance_sheet (quarterly, 2025-12-31) — Current Provisions: 215000000.00
BSN.DE cash_flow (annual, 2025-12-31) — Deferred Tax: -60000000.00
BSN.DE cash_flow (annual, 2025-12-31) — Depreciation: 1355000000.00
BSN.DE cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 1355000000.00
BSN.DE balance_sheet (annual, 2025-12-31) — Derivative Product Liabilities: 312000000.00
BSN.DE balance_sheet (quarterly, 2025-12-31) — Derivative Product Liabilities: 312000000.00
BSN.DE income_statement (annual, 2025-12-31) — Diluted Average Shares: 645130545.00
BSN.DE income_statement (annual, 2025-12-31) — Diluted EPS: 2.82
BSN.DE income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 1817000000.00
BSN.DE income_statement (annual, 2025-12-31) — EBIT: 3034000000.00
BSN.DE income_statement (annual, 2025-12-31) — EBITDA: 4389000000.00
BSN.DE cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: -307000000.00
BSN.DE cash_flow (annual, 2025-12-31) — End Cash Position: 737000000.00
BSN.DE balance_sheet (annual, 2025-12-31) — Financial Assets: 84000000.00
BSN.DE balance_sheet (quarterly, 2025-12-31) — Financial Assets: 84000000.00
BSN.DE cash_flow (annual, 2025-12-31) — Financing Cash Flow: -1610000000.00
BSN.DE balance_sheet (annual, 2025-12-31) — Finished Goods: 1325000000.00
BSN.DE balance_sheet (quarterly, 2025-12-31) — Finished Goods: 1325000000.00
BSN.DE cash_flow (annual, 2025-12-31) — Free Cash Flow: 2724000000.00
BSN.DE cash_flow (annual, 2025-12-31) — Gain Loss On Sale Of PPE: -1000000.00
BSN.DE income_statement (annual, 2025-12-31) — General And Administrative Expense: 2996000000.00
BSN.DE balance_sheet (annual, 2025-12-31) — Goodwill: 17275000000.00
BSN.DE balance_sheet (quarterly, 2025-12-31) — Goodwill: 17275000000.00
BSN.DE balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 23136000000.00
BSN.DE balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 23136000000.00
BSN.DE balance_sheet (annual, 2025-12-31) — Gross Accounts Receivable: 3152000000.00
BSN.DE balance_sheet (quarterly, 2025-12-31) — Gross Accounts Receivable: 3152000000.00
BSN.DE balance_sheet (annual, 2025-12-31) — Gross PPE: 16789000000.00
BSN.DE balance_sheet (quarterly, 2025-12-31) — Gross PPE: 16789000000.00
BSN.DE income_statement (annual, 2025-12-31) — Gross Profit: 13810000000.00
BSN.DE balance_sheet (annual, 2025-12-31) — Hedging Assets Current: 79000000.00
BSN.DE balance_sheet (quarterly, 2025-12-31) — Hedging Assets Current: 79000000.00
BSN.DE balance_sheet (annual, 2025-12-31) — Held To Maturity Securities: 121000000.00
BSN.DE balance_sheet (quarterly, 2025-12-31) — Held To Maturity Securities: 121000000.00
BSN.DE income_statement (annual, 2025-12-31) — Impairment Of Capital Assets: 225000000.00
BSN.DE income_statement (annual, 2025-12-31) — Interest Expense: 498000000.00
BSN.DE income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 498000000.00
BSN.DE income_statement (annual, 2025-12-31) — Interest Income: 301000000.00
BSN.DE income_statement (annual, 2025-12-31) — Interest Income Non Operating: 301000000.00
BSN.DE cash_flow (annual, 2025-12-31) — Interest Paid Cff: -5000000.00
BSN.DE balance_sheet (annual, 2025-12-31) — Inventories Adjustments Allowances: -205000000.00
BSN.DE balance_sheet (quarterly, 2025-12-31) — Inventories Adjustments Allowances: -205000000.00
BSN.DE balance_sheet (annual, 2025-12-31) — Inventory: 2325000000.00
BSN.DE balance_sheet (quarterly, 2025-12-31) — Inventory: 2325000000.00
BSN.DE balance_sheet (annual, 2025-12-31) — Invested Capital: 30398000000.00
BSN.DE balance_sheet (quarterly, 2025-12-31) — Invested Capital: 30398000000.00
BSN.DE cash_flow (annual, 2025-12-31) — Investing Cash Flow: -1773000000.00
BSN.DE balance_sheet (annual, 2025-12-31) — Investmentin Financial Assets: 626000000.00
BSN.DE balance_sheet (quarterly, 2025-12-31) — Investmentin Financial Assets: 626000000.00
BSN.DE balance_sheet (annual, 2025-12-31) — Investments In Other Ventures Under Equity Method: 1008000000.00
BSN.DE balance_sheet (quarterly, 2025-12-31) — Investments In Other Ventures Under Equity Method: 1008000000.00
BSN.DE cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 89000000.00
BSN.DE cash_flow (annual, 2025-12-31) — Issuance Of Debt: 2164000000.00
BSN.DE balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 730000000.00
BSN.DE balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 730000000.00
BSN.DE balance_sheet (annual, 2025-12-31) — Long Term Debt: 9031000000.00
BSN.DE balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 9031000000.00
BSN.DE balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 9761000000.00
BSN.DE balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 9761000000.00
BSN.DE cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 2164000000.00
BSN.DE cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -2050000000.00
BSN.DE balance_sheet (annual, 2025-12-31) — Long Term Equity Investment: 1008000000.00
BSN.DE balance_sheet (quarterly, 2025-12-31) — Long Term Equity Investment: 1008000000.00
BSN.DE balance_sheet (annual, 2025-12-31) — Long Term Provisions: 721000000.00
BSN.DE balance_sheet (quarterly, 2025-12-31) — Long Term Provisions: 721000000.00
BSN.DE balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 9123000000.00
BSN.DE balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 9123000000.00